The potential use of 29 kDa protein as a marker of pathogenicity and diagnosis of symptomatic infections with Blastocystis hominis.

Authors:
Address: Department of Parasitology, Faculty of Medicine, Ain Shams University, Ramsis St., Abbassia, 11566, Cairo, Egypt.
Journal:


Publication:

abstract

The present study was performed to characterize the protein profiles of Blastocystis hominis isolates from symptomatic and asymptomatic individuals by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting using sera from symptomatic and asymptomatic patients. The presence of immunogenic bands associated with pathogenicity or of diagnostic potentials was also evaluated. The study comprised 80 individuals classified into four groups, 20 each: symptomatic blastocystosis (G1), asymptomatic blastocystosis (G2), other parasitic infections (G3), and healthy control subjects (G4). SDS-PAGE analysis of individual antigens form symptomatic and asymptomatic B. hominis isolates revealed similar and distinctive antigenic bands with significant differences in two high (123.5 and 112.3 kDa) and few low molecular weight bands (48.5, 38, 42.3, and 35.5 kDa). Immunoblotting was performed using symptomatic and asymptomatic antigen pools with sera of the four studied groups. It was found that anti-B. hominis IgG reacted with nine protein bands ranging from 100 to 18 kDa of the symptomatic antigen pool. There was a significant difference between G1 and G2 in the recognition of 64, 56, 38, and 29 kDa antigen bands. Also, anti-B. hominis IgG reacted with five protein bands ranging from 56 to 12 kDa of asymptomatic antigen pool. There was a significant difference between G1 and G2 in the recognition of 29 kDa antigen band. These findings suggest the potential use of the 29-kDa antigen as marker of pathogenicity and implicate its use in the diagnosis and differentiation between symptomatic and asymptomatic blastocystosis.



Related Articles
Secretory and humoral antibody responses to Blastocystis hominis in symptomatic and asymptomatic human infections.
J Egypt Soc Parasitol. 2003
Secretory and humoral antibody responses to Blastocystis hominis in symptomatic and asymptomatic human infections.
Mahmoud MS, Saleh WA. J Egypt Soc Parasitol. 2003 Apr; 33(1):13-30.
Serologic response to Blastocystis hominis infection in asymptomatic individuals.
Tokai J Exp Clin Med. 2000
Serologic response to Blastocystis hominis infection in asymptomatic individuals.
Kaneda Y, Horiki N, Cheng X, Tachibana H, Tsutsumi Y. Tokai J Exp Clin Med. 2000 Jun; 25(2):51-6.
Kinetic analysis of antibody responses to Blastocystis hominis in sera and intestinal secretions of orally infected mice.
Parasitol Res. 2009
Kinetic analysis of antibody responses to Blastocystis hominis in sera and intestinal secretions of orally infected mice.
Santos HJ, Rivera WL. Parasitol Res. 2009 Oct; 105(5):1303-10. Epub 2009 Jul 14.
Review [Is Blastocystis hominis an opportunist agent?].
Turkiye Parazitol Derg. 2007
Review [Is Blastocystis hominis an opportunist agent?].
Al FD, Hökelek M. Turkiye Parazitol Derg. 2007; 31(1):28-36.
Review [Blastocystis hominis: in search of a disease, a misunderstood organism].
Presse Med. 1992
Review [Blastocystis hominis: in search of a disease, a misunderstood organism].
Ayadi A, Dutoit E, Camus D. Presse Med. 1992 Oct 24; 21(35):1677-9.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.